Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 153

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 16C
Chunk 153
---
 warrant programs. See“ Item 6 - Directors, Senior Management and Employees - B. Compensation”for more details on the RSU and warrant programs. Genmab made purchases of its ordinary shares under the March Share Buy-Back Program in support of Genmab’s capital allocation strategy.

  Period                                     Total Number of Shares Purchased      Average Price Paid per Share      Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs  
                                                                                                         in DKK                                                                                        
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Share Repurchase Programs                                                                                                                                                                            
  February 15, 2024 - February 29, 2024                               135,000                          1,985.50                                                                               135,000  
  March 1, 2024 - March 31, 2024                                      176,123                          2,042.36                                                                               176,123  
  April 2, 2024 - April 30, 2024                                      519,806                          2,017.16                                                                               519,806  
  May 1, 2024 - May 31, 2024                                          391,492                          1,952.10                                                                               391,492  
  June 3, 2024 - June 26, 2024                                        789,432                          1,821.83                                                                               789,432  
  Total                                                             2,011,853                                                                                                               2,011,853  

The February Share Buy-Back Program was conducted pursuant to authorization of our shareholders to repurchase up to 500,000 shares with a nominal value of DKK 500,000, given in April 2021, which expires in April 2026 (the “2021 Authorization”). No shares remain to be repurchased under the February Share Buy-Back Program, but up to 50,000 shares are authorized for repurchase by the shareholders pursuant to the 2021 Authorization, should additional share buy-back programs be implemented in the future.

The March Share Buy-Back Program was conducted pursuant to authorization of our shareholders to repurchase up to 3,500,000 shares with a nominal value of DKK 3,500,000, given in March 2024, which expires in March 2029 (the “2024 Authorization”). The March Share Buy-Back Program resulted in the repurchase of 1,821